MRNA: Moderna Inc Company Profile & Statistics

About

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency use in several countries as COVID-19 vaccine. The company has also developed booster doses of its COVID-19 vaccine and is developing variant-specific booster candidates.

Info & Links

CEO

Stephane Bancel

Headquarters

200 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

5,600

Moderna Inc Statistics

Valuation Measures

Market Capitalization²

19.33B

Enterprise Value

17.43B

Enterprise Value/EBITDA(ttm)

-4.16

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

4.06

Price to Book(mrq)

1.75

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

34.84%

Operating Margin(ttm)

-54.79%

Profit Margin(ttm)

-356.21%

Return on Equity(ttm)

-21.35%

Return on Invested Capital(ttm)

-43.55%

Return on Assets(ttm)

-15.75%

Income Statement

Revenue(ttm)

5.05B

Revenue Per Share(ttm)

13.14

Gross Profit(ttm)

1.67B

EBITDA(ttm)³

-4.19B

Net Income Available to Common(ttm)

-5.87B

Diluted EPS(ttm)

-15.38

Share Statistics

Beta (5Y Monthly)

1.69

52-Week Change

-31.73%

S&P 500 52-Week Change

36.42%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

384.40M

Dividend Yield

0.00%

Float⁴

324.05M

% Held by Insiders

15.70%

% Held by Institutions

75.33%

Balance Sheet

Total Cash(mrq)

8.49B

Total Cash Per Share(mrq)

22.08

Total Debt(mrq)

576.00M

Total Debt/Equity(mrq)

4.92%

Current Ratio(mrq)

4.09%

Quick Ratio(mrq)

3.92%

Book Value Per Share(mrq)

30.50

Cash Flow

Operating Cash Flow Per Share(ytd)

-5.89

Free Cash Flow(ytd)

-2.64B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

MRNA

Moderna Inc

Moderna Inc Profile